🚀 How BioMan4R2 is Powering Innovation at JAFRAL Biosolutions! 

⏩ Check out our #17 BioMan4R2 Success Story! 

🏅 JAFRAL Biosolutions -one of the awarded companies within the 𝘽𝙐𝙎𝙄𝙉𝙀𝙎𝙎 𝙏𝙍𝘼𝙉𝙎𝙁𝙊𝙍𝙈𝘼𝙏𝙄𝙊𝙉 𝙁𝙄𝙉𝘼𝙉𝘾𝙄𝘼𝙇 𝙎𝙐𝙋𝙋𝙊𝙍𝙏 category- is a true pioneer in the 𝙛𝙞𝙜𝙝𝙩 𝙖𝙜𝙖𝙞𝙣𝙨𝙩 𝙖𝙣𝙩𝙞𝙗𝙞𝙤𝙩𝙞𝙘 𝙧𝙚𝙨𝙞𝙨𝙩𝙖𝙣𝙘𝙚 𝙩𝙝𝙧𝙤𝙪𝙜𝙝 𝙥𝙝𝙖𝙜𝙚 𝙩𝙝𝙚𝙧𝙖𝙥𝙮. 🌍🦠

🔬 𝙅𝘼𝙁𝙍𝘼𝙇: 𝙖 𝙬𝙤𝙧𝙡𝙙-𝙡𝙚𝙖𝙙𝙚𝙧 𝙞𝙣 𝙋𝙝𝙖𝙜𝙚 𝙏𝙝𝙚𝙧𝙖𝙥𝙮 𝙏𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮
As a world leader in phage therapy, 𝙅𝘼𝙁𝙍𝘼𝙇 has been at the forefront of innovation since 2011. Phages, which are natural bacteria killers, offer a groundbreaking solution to overcome antibiotic resistance—a challenge so severe that the World Health Organization estimates it could cause more deaths by 2050 than cancer.

📈 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙀𝙭𝙘𝙚𝙡𝙡𝙚𝙣𝙘𝙚
Over the years, 𝙅𝘼𝙁𝙍𝘼𝙇 has produced more Clinical Trial material than any other company globally, providing critical treatments to patients and advancing the use of phage therapy in healthcare.

🏗️ 𝙈𝙖𝙣𝙖𝙜𝙞𝙣𝙜 𝙖 𝘾𝙤𝙢𝙥𝙡𝙚𝙭 𝘽𝙞𝙤𝙩𝙚𝙘𝙝 𝙀𝙘𝙤𝙨𝙮𝙨𝙩𝙚𝙢
Operating in the biotech industry means navigating a complex web of service providers and adhering to stringent Good Manufacturing Practices (GMP). From raw material supply to equipment maintenance, waste disposal, validation, and testing—every part of the production process requires seamless coordination.

💻 𝙏𝙝𝙚 𝙅𝙖𝙣𝙚𝙩 𝙎𝙤𝙛𝙩𝙬𝙖𝙧𝙚 𝙎𝙤𝙡𝙪𝙩𝙞𝙤𝙣
JAFRAL Biosolutions has developed Janet, a software solution that has revolutionized how they manage their production system. With the funding, they have built a specialized module that allows them to better manage their service providers, ensuring smoother operations and full compliance with regulatory standards.

This support has helped JAFRAL Biosolutions strengthen its position as a global leader in phage therapy and further its mission to combat antibiotic resistance. 🌟